2. UroToday Home
  3. Video Lectures

nmCRPC Videos

nmCRPC
Long-term Follow-up of Non-metastatic (M0) Patients in the STAMPEDE Randomized Trial - Interview with Nicholas James
October 9, 2019
Details
nmCRPC
ARAMIS Trial in Prostate Cancer: Impact of Darolutamide on Pain and Quality of Life - Karim Fizazi
June 5, 2019
Details
nmCRPC
Abiraterone Acetate for nmCRPC, The Forgotten Dance Partner? - Zach Klaassen and Chris Wallis
December 12, 2018
Details
nmCRPC
IMAAGEN Trial: A Look into the Non-Metastatic Prostate Cancer Space - Charles Ryan
November 6, 2018
Details
nmCRPC
Comparison Between Surgery and Radiotherapy in the Treatment of Non-Metastatic Prostate Cancer- Christopher Wallis
November 2, 2018
Details
nmCRPC
Phase III ARAMIS Trial Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint - Tom Keane
October 24, 2018
Details
nmCRPC
Combination Therapies and Quality of Life Data in Prostate Cancer - Fred Saad
October 11, 2018
Details
nmCRPC
nmCRPC Patient Population - Discussion with Charles Ryan and Alicia Morgans
October 8, 2018
Details
nmCRPC
The PROSPER Trial: Chemotherapy-Related Endpoints in Patients with nmCRPC - Neal Shore
August 14, 2018
Details
nmCRPC
AUA Castration-Resistant Prostate Cancer Guidelines - Interview with Michael Cookson
May 20, 2018
Details
nmCRPC
The Incredible Shrinking nmCRPC - Phillip Koo
May 14, 2018
Details
nmCRPC
The Implications of the SPARTAN Trial in the treatment of nmCRPC in Clinical Practice - Conversation with Eric Small
April 28, 2018
Details
nmCRPC
First presentation of SPARTAN - a phase 3 double-blind, randomized study of apalutamide (APA) versus placebo in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) - Eric Small
April 18, 2018
Details
nmCRPC
nmCRPC Outcomes in the Use of New Androgen Receptor Targeted Therapies - A Conversation with Charles Ryan and Alicia Morgans
April 3, 2018
Details
nmCRPC
nmCRPC - Early Treatment Leading to Favorable Outcomes - Fred Saad.
March 22, 2018
Details
nmCRPC
SPARTAN: A Study of Apalutamide in Men with M0 Castration-Resistant Prostate Cancer (M0 CRPC) - Alan Bryce
March 21, 2018
Details
nmCRPC
Meeting an Unmet Need in the Nonmetastatic Castration Resistant Prostate Cancer Patient Population - Maha Hussain
March 19, 2018
Details
nmCRPC
Changing the Landscape of nmCRPC - The SPARTAN Trial - Eric Small
March 6, 2018
Details
nmCRPC
M0 CRPC: Clinical Entity or Diagnostic Dilemma - Brett Carver
April 18, 2017
Details
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe